- idUS
- Listar por autor
Listar por autor "Boyero, Laura"
Mostrando ítems 1-4 de 4
-
Artículo
Correlation of peripheral blood biomarkers with clinical outcomes in NSCLC patients with high PD-L1 expression treated with pembrolizumab
Sánchez-Gastaldo, Amparo; Muñoz-Fuentes, Miguel A.; Molina-Pinelo, Sonia; Alonso-García, Miriam; Boyero, Laura; Bernabé-Caro, Reyes (2021)Background: Immune checkpoint inhibitors (ICIs) are currently the standard therapy in advanced non small cell lung cancer ...
-
Artículo
Primary and acquired resistance to immunotherapy in lung cancer: unveiling the mechanisms underlying of immune checkpoint blockade therapy
Boyero, Laura; Sanchez-Gastaldo, Amparo; Alonso, Miriam; Noguera Uclés, José Francisco; Molina Pinelo, Sonia; Bernabé-Caro, Reyes (MDPI, 2020-12-11)After several decades without maintained responses or long-term survival of patients with lung cancer, novel therapies ...
-
Artículo
Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
Alonso-García, Miriam; Sánchez-Gastaldo, Amparo; Muñoz-Fuentes, Miguel A.; Molina-Pinelo, Sonia; Boyero, Laura; Benedetti, Johana Cristina; Bernabé-Caro, Reyes (MDPI, 2022)Nivolumab (anti-PD-1 antibody) and atezolizumab (anti-PD-L1 antibody) have shown superior survival outcomes and improved ...
-
Artículo
The roles of imprinted SLC22A18 and SLC22A18AS gene overexpression caused by promoter CPG island hypomethylation as diagnostic and prognostic biomarkers for non-small cell lung cancer patients
Noguera-Uclés, José Francisco; Boyero, Laura; Salinas, Ana; Varela, Juan Antonio Cordero; Benedetti, Johana Cristina; Bernabé-Caro, Reyes; Molina-Pinelo, Sonia (MDPI, 2020)Genomic imprinting is a process that involves one gene copy turned-off in a parent-of-origin-dependent manner. The regulation ...